Meeting
2013 ASCO Annual Meeting
Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study—A study of the Dutch Head and Neck Society.
Authors
Chantal Driessen
Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Chantal Driessen , J. P. De Boer , Hans Gelderblom , Coen R.N. Rasch , Martin de Jong , Berit M Verbist , Margot Et Tesselaar , Winette T.A. Van Der Graaf , J. H. Kaanders , Carla M.L.- Van Herpen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Clinical Trial Registration Number
NCT00774319
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6057)
DOI
10.1200/jco.2013.31.15_suppl.6057
Abstract #
6057
Poster Bd #
12E
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Quality of life of patients with locally advanced head and neck cancer (LAHNC) treated with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing chemoradiotherapy (CRT).
First Author: Chantal Driessen
Poster
2014 ASCO Annual Meeting
Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.
First Author: Erminia Massarelli
Poster
2013 ASCO Annual Meeting
Induction chemotherapy (CT) with docetaxel, cisplatin, and fluorouracil (TPF) followed by concomitant cisplatin plus radiotherapy in locally advanced nasopharyngeal cancer (NPC): Results after 06 years.
First Author: Esma Kerboua
First Author: Maria Grazia Ghi